Nuvation Bio Inc.
NUVB
$4.32
-$0.40-8.48%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 143.05M | 62.90M | 26.75M | 14.36M | 10.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 143.05M | 62.90M | 26.75M | 14.36M | 10.96M |
| Cost of Revenue | 13.20M | 9.30M | 12.24M | 10.40M | 9.17M |
| Gross Profit | 129.85M | 53.60M | 14.51M | 3.95M | 1.79M |
| SG&A Expenses | 154.48M | 151.56M | 137.37M | 119.60M | 97.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 293.23M | 275.97M | 259.72M | 238.99M | 217.32M |
| Operating Income | -150.18M | -213.06M | -232.97M | -224.64M | -206.36M |
| Income Before Tax | -145.99M | -204.63M | -217.48M | -202.90M | -606.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -145.99 | -204.63 | -217.48 | -202.90 | -606.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -145.99M | -204.63M | -217.48M | -202.90M | -606.38M |
| EBIT | -150.18M | -213.06M | -232.97M | -224.64M | -206.36M |
| EBITDA | -148.21M | -211.33M | -231.55M | -223.59M | -205.43M |
| EPS Basic | -0.43 | -0.60 | -0.64 | -0.63 | -2.34 |
| Normalized Basic EPS | -0.27 | -0.37 | -0.40 | -0.39 | -0.38 |
| EPS Diluted | -0.43 | -0.60 | -0.64 | -0.63 | -2.35 |
| Normalized Diluted EPS | -0.27 | -0.37 | -0.40 | -0.39 | -0.38 |
| Average Basic Shares Outstanding | 1.37B | 1.37B | 1.36B | 1.29B | 1.19B |
| Average Diluted Shares Outstanding | 1.37B | 1.37B | 1.36B | 1.29B | 1.19B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |